Mary E. Rinella
Department of Medicine
Mary E. Rinella is the director of the Metabolic and Fatty Liver Diseases Program. Her clinical research focus is on nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), both prior to and after liver transplantation. She is actively involved in the American Association for the Study of Liver Diseases (AASLD), where she serves as councilor-at-large on its governing board. She has held several national leadership roles, including chair of the AASLD NAFLD Special Interest Group and chair of the AASLD NASH Task Force, which is charged with fostering research collaboration and advancing best practices through collaboration with other medical societies, federal agencies, and patient advocacy organizations to improve outcomes in patients with NAFLD/NASH.
Rinella’s scholarship has been published in journals that include Alimentary Pharmacology and Therapeutics, Gastroenterology, Nature Reviews: Gastroenterology & Hepatology, Journal of Hepatology, Transplantation Direct, Clinical Gastroenterology and Hepatology, Hepatology, Journal of the American Heart Association, Contemporary Clinical Trials, The Lancet, Digestive Diseases and Sciences, Transplant Proceedings, Journal of General Internal Medicine, American Journal of Gastroenterology, Liver International, and Obesity.
Rinella received her MD from the University of Illinois College of Medicine. She completed an internship and residency at the University of Chicago Medicine, and a fellowship in gastroenterology and hepatology at Northwestern University, where she was recently a professor of medicine.